As the growing human population continues to age, there is an increasing incidence of chronic diseases, such as cancer and coronary artery disease. Traditionally, conditions such as these have required multimodality imaging (i.e., CT, MRI, PET/CT, and ultrasound) to both initially diagnose and monitor for response after initiation of therapy. However, the wide availability, growing technologic advances, and ongoing research have allowed for CT to leap forward from a modality traditionally grounded in purely anatomic imaging to one with the capability of yielding clinically relevant functional information on par with that of other radiologic exams. In this chapter, we provide an overview of CT sub-modalities and applications highlighting and placing emphasis on how CT imaging can transition from a merely anatomic to a functional imaging modality.
KeywordsCT Dual-energy CT Functional imaging Oncologic imaging Material decomposition Cellular tracking
Thank you to Dr. Ryan O’Malley for contributing a CT case of pancreatic tumor perfusion.
- 8.Taylor AJ, Cerqueira M, Hodgson JM, Mark D, Min J, O’Gara P, et al. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation appropriate use criteria task force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. Circulation. 2010;122(21):e525–55. https://doi.org/10.1161/CIR.0b013e3181fcae66.CrossRefPubMedGoogle Scholar
- 13.Lotfi A, Jeremias A, Fearon WF, Feldman MD, Mehran R, Messenger JC, et al. Expert consensus statement on the use of fractional flow reserve, intravascular ultrasound, and optical coherence tomography: a consensus statement of the Society of Cardiovascular Angiography and Interventions. Cathet Cardiovasc Interv: Off J Soc Card Angiography Interv. 2014;83(4):509–18. https://doi.org/10.1002/ccd.25222.CrossRefGoogle Scholar
- 21.Selby MG, Vrtiska TJ, Krambeck AE, McCollough CH, Elsherbiny HE, Bergstralh EJ, et al. Quantification of asymptomatic kidney stone burden by computed tomography for predicting future symptomatic stone events. Urology. 2015;85(1):45–50. https://doi.org/10.1016/j.urology.2014.08.031.CrossRefPubMedGoogle Scholar
- 26.Raatschen HJ, Fu Y, Brasch RC, Pietsch H, Shames DM, Yeh BM. In vivo monitoring of angiogenesis inhibitory treatment effects by dynamic contrast-enhanced computed tomography in a xenograft tumor model. Investig Radiol. 2009;44(5):265–70. https://doi.org/10.1097/RLI.0b013e31819f1b60.CrossRefGoogle Scholar
- 27.Bhavane R, Badea C, Ghaghada KB, Clark D, Vela D, Moturu A, et al. Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent. Circ Cardiovasc Imaging. 2013;6(2):285–94. https://doi.org/10.1161/circimaging.112.000119.CrossRefPubMedPubMedCentralGoogle Scholar
- 32.Menk RH, Schultke E, Hall C, Arfelli F, Astolfo A, Rigon L, et al. Gold nanoparticle labeling of cells is a sensitive method to investigate cell distribution and migration in animal models of human disease. Nanomed: Nanotechnol Biol Med. 2011;7(5):647–54. https://doi.org/10.1016/j.nano.2011.01.010.CrossRefGoogle Scholar